Gasthuys Elke, Devreese Mathias, Millecam Joske, Sys Stanislas, Vanderperren Katrien, Delanghe Joris, Vande Walle Johan, Heyndrickx Marjolein, Croubels Siska
Department of Toxicology, Pharmacology and Biochemistry, Faculty of Veterinary Medicine, Ghent UniversityMerelbeke, Belgium.
Department of Internal Medicine and Clinical Biology of Large Animals, Faculty of Veterinary Medicine, Ghent UniversityMerelbeke, Belgium.
Front Pharmacol. 2017 Jun 29;8:431. doi: 10.3389/fphar.2017.00431. eCollection 2017.
Adequate animal models are required to study the preclinical pharmacokinetics (PK), pharmacodynamics (PD) and safety of drugs in the pediatric subpopulation. Over the years, pigs were presented as a potential animal model, since they display a high degree of anatomical and physiological similarities with humans. To assess the suitability of piglets as a preclinical animal model for children, the ontogeny and maturation processes of several organ systems have to be unraveled and compared between both species. The kidneys play a pivotal role in the PK and PD of various drugs, therefore, the glomerular filtration rate (GFR) measured as clearance of endogenous creatinine (Jaffe and enzymatic assay) and exo-iohexol was determined in conventional piglets aging 8 days ( = 16), 4 weeks ( = 8) and 7 weeks ( = 16). The GFR data were normalized to bodyweight (BW), body surface area (BSA) and kidney weight (KW). Normalization to BSA and KW showed an increase in GFR from 46.57 to 100.92 mL/min/m and 0.49 to 1.51 mL/min/g KW from 8 days to 7 weeks of age, respectively. Normalization to BW showed a less pronounced increase from 3.55 to 4.31 mL/min/kg. The postnatal development of the GFR was comparable with humans, rendering the piglet a convenient juvenile animal model for studying the PK, PD and safety of drugs in the pediatric subpopulation. Moreover, to facilitate the assessment of the GFR in growing piglets in subsequent studies, a formula was elaborated to estimate the GFR based on plasma creatinine and BW, namely eGFR =1.879 × BW[Formula: see text].
需要合适的动物模型来研究儿科亚群中药物的临床前药代动力学(PK)、药效学(PD)和安全性。多年来,猪被认为是一种潜在的动物模型,因为它们在解剖学和生理学上与人类有高度的相似性。为了评估仔猪作为儿童临床前动物模型的适用性,必须阐明并比较两种物种几个器官系统的个体发生和成熟过程。肾脏在各种药物的PK和PD中起关键作用,因此,在8日龄(n = 16)、4周龄(n = 8)和7周龄(n = 16)的常规仔猪中测定了以内源性肌酐清除率(Jaffe法和酶法)和外源性碘海醇测量的肾小球滤过率(GFR)。GFR数据按体重(BW)、体表面积(BSA)和肾脏重量(KW)进行标准化。按BSA和KW标准化显示,从8日龄到7周龄,GFR分别从46.57增加到100.92 mL/min/m²和从0.49增加到1.51 mL/min/g KW。按BW标准化显示增加不太明显,从3.55增加到4.31 mL/min/kg。GFR的出生后发育与人类相当,使仔猪成为研究儿科亚群中药物的PK、PD和安全性的方便的幼年动物模型。此外,为便于在后续研究中评估生长中仔猪的GFR,制定了一个基于血浆肌酐和BW估计GFR的公式,即eGFR =1.879×BW[公式:见正文] 。